TL1A/TNFR2 Axis Enhances Immunoregulatory Effects of Bone Marrow Derived Mesenchymal Stem Cell by Indian Hedgehog Signaling Pathway

被引:4
作者
Al-Azab, Mahmoud [1 ,2 ]
Walana, Williams [1 ,7 ]
Wei, Jing [1 ]
Li, Weiping [1 ]
Tang, Yawei [1 ]
Wei, Xiaoqing [3 ]
Almoiliqy, Marwan [4 ]
Shopit, Abdullah [4 ]
Abbas, Elrayah Eltahir [5 ]
Adlat, Salah [6 ]
Awsh, Mohammed [4 ]
Li, Xia [1 ]
Wang, Bing [1 ]
机构
[1] Dalian Med Univ, Coll Basic Med Sci, Dept Immunol, Lvshun South Rd, Dalian 116044, Liaoning, Peoples R China
[2] Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Guangzhou Inst Pediat, Dept Immunol, Guangzhou, Peoples R China
[3] Dalian Med Univ, Coll Basic Med Sci, Mol Med Lab, Dalian, Liaoning, Peoples R China
[4] Dalian Med Univ, Coll Pharm, Dept Pharmacol, Dalian, Liaoning, Peoples R China
[5] Dalian Med Univ, Coll Basic Med Sci, Microbiol Lab, Dalian, Liaoning, Peoples R China
[6] Northeast Normal Univ, Sch Life Sci, Key Lab Mol Epigenet, MOE, Changchun, Peoples R China
[7] Univ Dev Studies, Sch Med & Hlth Sci, Dept Clin Microbiol, Tamale, Ghana
基金
中国国家自然科学基金;
关键词
Bone marrow-derived mesenchymal stem cells; Tumor necrosis factor-like ligand 1A; TNF-receptor; 2; Indian hedgehog; FIBROBLAST-LIKE SYNOVIOCYTES; STROMAL CELLS; INTERFERON-GAMMA; T-CELL; TL1A; DR3; DIFFERENTIATION; PROLIFERATION; MIGRATION;
D O I
10.15283/ijsc19121
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Background and Objectives: The immunomodulatory potential of mesenchymal stem cells (MSCs) can be regulated by a variety of molecules, especially cytokines. The inflammatory cytokine, TNF-like ligand 1A (TL1A), has been reported as an inflammation stimulator in-multiple autoimmune diseases. Here, we studied the effects of TL1A/TNF-receptor 2 (TNFR2) pathway on the therapeutic potency of bone marrow-derived MSCs (BMSCs). Methods and Results: BMSCs, fibroblast-like synoviocytes (FLSs), and H9 and jurkat human T lymphocytes were used in this study. BMSCs paracrine activities, differentiation, proliferation, and migration were investigated after stimulation with TL1A, and intervened with anti-TNFR2. Additionally, the effects of TL1A on BMSCs therapeutic potency were evaluated by treating RA-FLSs, and H9 and jurkat T cells with TL1A-stimulated BMSCs conditioned medium (CM). Indian hedgehog (IHH) involvement was determined by gene silencing and treatment by recombinant IHH (rIHH). TL1A induced BMSCs stemness-related genes, COX-2, IL-6, IDO, TGF-beta and HGF through TNFR2. Also, TL1A corrected biased differentiation and increased proliferation, and migration through TNFR2. Meanwhile, CM of TL1A-stimulated BMSCs decreased the inflammatory markers of RA-FLSs and T cells. Moreover, TL1A-stimulated BMSCs experienced IHH up-regulation coupled with NF-kappa B and STAT3 signaling up-regulation, while p53 and oxidative stress were down-regulated. Furthermore, treatment of BMSCs by rIHH increased their anti-inflammatory effects. More importantly, knockdown of IHH decreased the ability of TL1A-stimulated BMSCs to alleviating the inflammation in RA-FLSs and T cells. Conclusions: This study reports the effects of TL1A/TNFR2 pathway on the biological behaviors and therapeutic potency of BMSCs through IHH. These findings could introduce novel procedures to increase the stemness of MSCs in cellular therapy.
引用
收藏
页码:58 / 73
页数:16
相关论文
共 50 条
[1]   Indian Hedgehog regulates senescence in bone marrow-derived mesenchymal stem cell through modulation of ROS/mTOR/4EBP1, p70S6K1/2 pathway [J].
Al-Azab, Mahmoud ;
Wang, Bing ;
Elkhider, Abdalkhalig ;
Walana, Williams ;
Li, Weiping ;
Yuan, Bo ;
Ye, Yunshan ;
Tang, Yawei ;
Almoiliqy, Marwan ;
Adlat, Salah ;
Wei, Jing ;
Zhang, Yan ;
Li, Xia .
AGING-US, 2020, 12 (07) :5693-5715
[2]   TL1A/TNFR2-mediated mitochondrial dysfunction of fibroblast-like synoviocytes increases inflammatory response in patients with rheumatoid arthritis via reactive oxygen species generation [J].
Al-Azab, Mahmoud ;
Qaed, Eskandar ;
Ouyang, Xunli ;
Elkhider, Abdalkhalig ;
Walana, Williams ;
Li, Han ;
Li, Weiping ;
Tang, Yawei ;
Adlat, Salah ;
Wei, Jing ;
Wang, Bing ;
Li, Xia .
FEBS JOURNAL, 2020, 287 (14) :3088-3104
[3]   TL1A mediates fibroblast-like synoviocytes migration and Indian Hedgehog signaling pathway via TNFR2 in patients with rheumatoid arthritis [J].
Al-Azab, Mahmoud ;
Wei, Jing ;
Ouyang, Xunli ;
Elkhider, Abdalkhalig ;
Walana, Williams ;
Sun, Xiaotong ;
Tang, Yawei ;
Wang, Bing ;
Li, Xia .
EUROPEAN CYTOKINE NETWORK, 2018, 29 (01) :27-35
[4]   The Role of Reactive Oxygen Species in Mesenchymal Stem Cell Adipogenic and Osteogenic Differentiation: A Review [J].
Atashi, Fatemeh ;
Modarressi, Ali ;
Pepper, Michael S. .
STEM CELLS AND DEVELOPMENT, 2015, 24 (10) :1150-1163
[5]   Interleukin-3 enhances the migration of human mesenchymal stem cells by regulating expression of CXCR4 [J].
Barhanpurkar-Naik, Amruta ;
Mhaske, Suhas T. ;
Pote, Satish T. ;
Singh, Kanupriya ;
Wani, Mohan R. .
STEM CELL RESEARCH & THERAPY, 2017, 8
[6]  
Bie QL, 2017, ONCOTARGET, V8, P18914, DOI 10.18632/oncotarget.14835
[7]   Mesenchymal stromal cell potency to treat acute kidney injury increased by ultrasound-activated interferon-γ/interleukin-10 axis [J].
Burks, Scott R. ;
Nagle, Matthew E. ;
Bresler, Michele N. ;
Kim, Saejeong J. ;
Star, Robert A. ;
Frank, Joseph A. .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (12) :6015-6025
[8]   IL-1β-Induced Matrix Metalloprotease-1 Promotes Mesenchymal Stem Cell Migration via PAR1 and G-Protein-Coupled Signaling Pathway [J].
Chen, Ming-Siou ;
Lin, Cheng-Yu ;
Chiu, Yun-Hsuan ;
Chen, Chie-Pein ;
Tsai, Pei-Jiun ;
Wang, Hwai-Shi .
STEM CELLS INTERNATIONAL, 2018, 2018
[9]   Interleukin-22 drives the proliferation, migration and osteogenic differentiation of mesenchymal stem cells: a novel cytokine that could contribute to new bone formation in spondyloarthropathies [J].
El-Zayadi, Ahmed A. ;
Jones, Elena A. ;
Churchman, Sarah M. ;
Baboolal, Thomas G. ;
Cuthbert, Richard J. ;
El-Jawhari, Jehan J. ;
Badawy, Ahmed M. ;
Alase, Adewonuola A. ;
El-Sherbiny, Yasser M. ;
McGonagle, Dennis .
RHEUMATOLOGY, 2017, 56 (03) :488-493
[10]  
FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267